First Generic of Once-Daily GLP-1 Injection Approved for Diabetes Generic liraglutide approved at dosage for type 2 diabetes only Dec 23, 2024
Study Underscores Caution for NSAID Use in Pregnancy Observational study details kidney disease risk for children after gestational exposure Dec 23, 2024
FDA Says Compounded Tirzepatide Must Exit the Market Compounders only have 2 to 3 months left to copy injectable Dec 19, 2024
Cardiovascular Protection Tracks With Wine Intake, Now Provable With Urinary Marker Biomarker of wine consumption believed to reduce misclassification and bias in study Dec 18, 2024
Woman Dialysis-Free After Receiving Gene-Edited Pig Kidney Clinical trials of xenotransplantation expected to kick off next year Dec 17, 2024
How 'General Hospital' Missed a Chance to Promote Living Organ Donation A recent storyline offered a negative spin Dec 16, 2024
Newer Diabetes Drugs Still Under-Prescribed in High-Risk Patients Cost, insurance coverage likely play outsized role Dec 16, 2024
The FDA Hasn't Inspected This Drug Factory After 7 Recalls for the Same Flaw With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing Dec 15, 2024
Medical Assistance in Dying; Health Benefits of Chocolate? Also in TTHealthWatch: depression treatment after positive screening in primary care Dec 14, 2024 podcast
Generous Blood Transfusions Not Beneficial for Some With Burst Brain Aneurysms SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients Dec 10, 2024
Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds Dec 10, 2024
Empathetic Phone Calls Help Vulnerable Diabetes Patients Lower HbA1c Social support may be key to improving glycemic control, experts say Dec 10, 2024
Could a Hypertension Drug Protect Against Post-Stroke Epilepsy? Observational study suggests one antihypertensive class might be preventive Dec 09, 2024
Are GLP-1 Drug Holidays a Risk Worth Taking? Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care Dec 08, 2024 video
GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots 20% lower risk of VTE observed in large retrospective study of diabetes patients Dec 08, 2024
Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included Existing models improved only slightly after accounting for certain female risk factors Dec 06, 2024
FDA Panned at Senate Hearing for Failure to Address Diabetes, Obesity Epidemics Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders Dec 05, 2024
Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy Dec 05, 2024
Untangling GLP-1 Risks: Are Side Effects Overblown? Experts tackle myths, data bias, and game-changing outcomes of obesity drugs Dec 05, 2024 video
New Study Teases Out Chocolate and Diabetes Connection Eating more dark chocolate was associated with a lower risk of type 2 diabetes Dec 04, 2024
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide Dec 04, 2024
Makers of Sickle Cell Disease Gene Therapy to Participate in Payment Model, CMS Says Outcomes-based model designed to improve access to pricey treatments Dec 04, 2024
New Rule Allows HIV-Positive Organ Transplants Previously, such transplants could be done only as part of research studies Nov 26, 2024
Many Drinkers Cut Back After Starting Obesity Meds, Study Finds In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
CGM Uptake Very Low for Vulnerable Diabetes Populations But how to achieve equitable use remains "complicated," says expert Nov 22, 2024
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
Metformin, Lifestyle Changes Fail to Reduce Afib Burden Standard of care prevails in single-center trial Nov 20, 2024
Potassium Binder Cuts Hyperkalemia Risk in HF Patients on Spironolactone More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients Nov 20, 2024
Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy Benefit shown in trial of patients flagged for high risk of cardiotoxicity Nov 20, 2024
Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adults Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts Nov 19, 2024
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy Most are eligible for weight management indication Nov 18, 2024
Multimarker Urine Test Promises to Improve Lupus Nephritis Diagnosis, Prognosis Accuracy above 85% in early testing -- far better than proteinuria and biopsy Nov 18, 2024
Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathy One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial Nov 17, 2024
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
Intensive Blood Pressure Control Benefits People With Type 2 Diabetes Too BPROAD trial replicates SPRINT trial findings in diabetes population in China Nov 16, 2024
Multiple Chronic Conditions and Death; Diabetes Treatment for Gout Also in TTHealthWatch: frailty as a predictor of dementia Nov 16, 2024 podcast
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024